[CROI--presentation of new study results. In a comparison of NNRTI nevirapine is equally effective].
D000480:Alkynes; D048588:Benzoxazines; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D019829:Nevirapine / Q000627:therapeutic use*; D010078:Oxazines / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome; D019562:Viral Load
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; C098320:efavirenz
CROI-Präsentation neuer Studienergebnisse. Im NNRTI-Vergleich holt Nevirapin auf.